1. Home
  2. RGEN vs SAIC Comparison

RGEN vs SAIC Comparison

Compare RGEN & SAIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • SAIC
  • Stock Information
  • Founded
  • RGEN 1981
  • SAIC 1969
  • Country
  • RGEN United States
  • SAIC United States
  • Employees
  • RGEN N/A
  • SAIC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • SAIC EDP Services
  • Sector
  • RGEN Health Care
  • SAIC Technology
  • Exchange
  • RGEN Nasdaq
  • SAIC Nasdaq
  • Market Cap
  • RGEN 6.5B
  • SAIC 5.6B
  • IPO Year
  • RGEN N/A
  • SAIC N/A
  • Fundamental
  • Price
  • RGEN $124.56
  • SAIC $104.93
  • Analyst Decision
  • RGEN Buy
  • SAIC Buy
  • Analyst Count
  • RGEN 9
  • SAIC 10
  • Target Price
  • RGEN $167.38
  • SAIC $131.10
  • AVG Volume (30 Days)
  • RGEN 663.7K
  • SAIC 450.4K
  • Earning Date
  • RGEN 07-29-2025
  • SAIC 09-04-2025
  • Dividend Yield
  • RGEN N/A
  • SAIC 1.41%
  • EPS Growth
  • RGEN N/A
  • SAIC 49.05
  • EPS
  • RGEN N/A
  • SAIC 8.26
  • Revenue
  • RGEN $673,956,000.00
  • SAIC $7,460,000,000.00
  • Revenue This Year
  • RGEN $16.74
  • SAIC $4.04
  • Revenue Next Year
  • RGEN $13.86
  • SAIC $2.21
  • P/E Ratio
  • RGEN N/A
  • SAIC $12.70
  • Revenue Growth
  • RGEN 8.73
  • SAIC 2.23
  • 52 Week Low
  • RGEN $102.97
  • SAIC $94.68
  • 52 Week High
  • RGEN $182.52
  • SAIC $156.34
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.93
  • SAIC 26.11
  • Support Level
  • RGEN $112.71
  • SAIC $102.00
  • Resistance Level
  • RGEN $124.91
  • SAIC $118.64
  • Average True Range (ATR)
  • RGEN 4.32
  • SAIC 2.83
  • MACD
  • RGEN 0.11
  • SAIC -1.55
  • Stochastic Oscillator
  • RGEN 80.23
  • SAIC 15.39

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

Share on Social Networks: